|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 995.00 INR | -1.42% |
|
+7.20% | +32.40% |
| 05-28 | Supriya Lifescience Limited, Q4 2026 Earnings Call, May 28, 2026 | |
| 05-27 | Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 80.08B 841M 735M 675M 629M 1.19B 1.21B 8.13B 3.15B 39.28B 3.16B 3.09B 135B | P/E 2026 |
21.6x | P/E 2027 * | 33.3x |
|---|---|---|---|---|---|
| Enterprise Value | 80.08B 841M 735M 675M 629M 1.19B 1.21B 8.13B 3.15B 39.28B 3.16B 3.09B 135B | EV / Sales 2026 |
5.46x | EV / Sales 2027 * | 8.06x |
| Free-Float |
28.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supriya Lifescience Limited
| 1 day | -1.42% | ||
| 1 week | +7.20% | ||
| Current month | -2.26% | ||
| 1 month | +8.48% | ||
| 3 months | +62.53% | ||
| 6 months | +32.57% | ||
| Current year | +32.40% |
| 1 week | 913.3 |  | 1,043.2 |
| 1 month | 880 | | 1,043.2 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 233.3 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 34 | 2024-07-31 | |
| Chief Executive Officer | 36 | 2024-07-31 | |
| Director of Finance/CFO | - | 2023-01-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2008-03-25 | |
| Director/Board Member | 41 | 2019-05-31 | |
| Director/Board Member | 36 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | +7.20% | +37.11% | +301.45% | 841M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| +2.93% | -1.94% | +26.41% | +20.22% | 339B | |
| -0.86% | +0.78% | +41.42% | +39.10% | 301B | |
| -0.31% | +1.11% | +31.90% | +44.21% | 292B | |
| -1.54% | +2.94% | -25.26% | -39.53% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.13% | +4.79% | +31.71% | +81.58% | 370.06B | |
| Weighted average by Cap. | +1.31% | +5.21% | +41.72% | +81.26% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.4B 88.24M 77.1M 70.8M 66.02M 125M 127M 852M 330M 4.12B 331M 324M 14.2B | 9.94B 104M 91.19M 83.74M 78.09M 148M 151M 1.01B 391M 4.87B 392M 383M 16.79B |
| Net income | 2B 21.02M 18.37M 16.87M 15.73M 29.82M 30.32M 203M 78.7M 981M 78.92M 77.21M 3.38B | 2.41B 25.3M 22.11M 20.3M 18.93M 35.9M 36.5M 244M 94.74M 1.18B 95.01M 92.95M 4.07B |
| Net Debt | - | - |
Employees
515
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | ₹995.00 | -1.42% | 342,595 |
| 26-07-01 | ₹1,009.30 | -0.86% | 301,102 |
| 26-06-30 | ₹1,018.05 | +4.87% | 1,116,775 |
| 26-06-29 | ₹970.75 | +4.59% | 373,588 |
| 26-06-25 | ₹928.15 | -2.61% | 294,546 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
